Health Tidings Mergers & AcquisitionsBioMarin Bolsters Its Rare Disease Portfolio Through Amicus Acquisition BioMarin Bolsters Its Rare Disease Portfolio Through Amicus Acquisition Read Post »
Mergers & AcquisitionsEli Lilly Bets Big on Next-Gen JAK2 Science with Ajax Therapeutics Deal Eli Lilly Bets Big on Next-Gen JAK2 Science with Ajax Therapeutics Deal Read Post »
Health Tidings Mergers & AcquisitionsSun Pharma Acquires Organon in $11.75 Billion Deal Sun Pharma Acquires Organon in $11.75 Billion Deal Read Post »
Mergers & AcquisitionsSerum Institute Joins VaxThera to Expand Vaccine Access in Colombia Serum Institute Joins VaxThera to Expand Vaccine Access in Colombia Read Post »
Mergers & AcquisitionsSerum Institute of India Teams with Oxford to Reinforce the Fight Against M... Serum Institute of India Teams with Oxford to Reinforce the Fight Against M... Read Post »
Regulatory & Health PolicyWHO Prequalification Elevates Novartis’ Coartem Baby in Malaria Care for ... WHO Prequalification Elevates Novartis’ Coartem Baby in Malaria Care for ... Read Post »
Regulatory & Health PolicyFDA Accelerates the Clock on Psychedelic Research After Federal Order FDA Accelerates the Clock on Psychedelic Research After Federal Order Read Post »
Health Tidings Mergers & AcquisitionsAbbVie Receives FDA Complete Response Letter for TrenibotulinumtoxinE AbbVie Receives FDA Complete Response Letter for TrenibotulinumtoxinE Read Post »
Mergers & AcquisitionsApotex to Acquire Cumberland’s Branded Drug Portfolio in $100M Deal Apotex to Acquire Cumberland’s Branded Drug Portfolio in $100M Deal Read Post »
Health Tidings Mergers & AcquisitionsAmneal Bets Big on Biosimilars with Kashiv Acquisition Amneal Bets Big on Biosimilars with Kashiv Acquisition Read Post »
Mergers & AcquisitionsMerck Builds AI-Enabled Enterprise with Support from Google Cloud Merck Builds AI-Enabled Enterprise with Support from Google Cloud Read Post »
Regulatory & Health PolicyNICE Greenlights Zanidatamab for Previously Treated Biliary Tract Cancer NICE Greenlights Zanidatamab for Previously Treated Biliary Tract Cancer Read Post »
Health Tidings Mergers & AcquisitionsCompass Pathways Builds the Path to Nationwide COMP360 Delivery with Osmind Compass Pathways Builds the Path to Nationwide COMP360 Delivery with Osmind Read Post »
Health Tidings Mergers & AcquisitionsBiogen Takes Full Control of Felzartamab from TJ Biopharma Biogen Takes Full Control of Felzartamab from TJ Biopharma Read Post »
Health Tidings Mergers & AcquisitionsEli Lilly to Acquire Kelonia Therapeutics for Up to $7 Billion, Advancing I... Eli Lilly to Acquire Kelonia Therapeutics for Up to $7 Billion, Advancing I... Read Post »
Health Tidings Regulatory & Health PolicyFederal Order Expands Access and Research for Psychedelic Therapies Federal Order Expands Access and Research for Psychedelic Therapies Read Post »
Health Tidings Mergers & AcquisitionsUCB Seeks to Rebuild Brain Balance with $1.15B Neurona Move UCB Seeks to Rebuild Brain Balance with $1.15B Neurona Move Read Post »
Health Tidings Mergers & AcquisitionsGilead Sciences, Inc. Clears Final Hurdles, Locks in Arcellx, Inc. Deal Gilead Sciences, Inc. Clears Final Hurdles, Locks in Arcellx, Inc. Deal Read Post »
Health Tidings Mergers & AcquisitionsVir Biotechnology Closes Astellas Deal to Advance VIR-5500 in Prostate Canc... Vir Biotechnology Closes Astellas Deal to Advance VIR-5500 in Prostate Canc... Read Post »
Mergers & AcquisitionsAligos and Amoytop Enter Strategic Licensing Pact for HBV Therapy in Greate... Aligos and Amoytop Enter Strategic Licensing Pact for HBV Therapy in Greate... Read Post »
Regulatory & Health PolicyFDA Lays the Groundwork for Expanding Testosterone Therapy’s Reach FDA Lays the Groundwork for Expanding Testosterone Therapy’s Reach Read Post »
Mergers & AcquisitionsMeiraGTx Takes the Lead on Bota-vec, Driving Toward Regulatory Approval in ... MeiraGTx Takes the Lead on Bota-vec, Driving Toward Regulatory Approval in ... Read Post »
Regulatory & Health PolicySandoz Plants a Strategic Supply Anchor in Africa with Rwanda Manufacturing... Sandoz Plants a Strategic Supply Anchor in Africa with Rwanda Manufacturing... Read Post »
Health Tidings Mergers & AcquisitionsIllumina and D3b Construct a Unified Genomic Core to Break Pediatric Data S... Illumina and D3b Construct a Unified Genomic Core to Break Pediatric Data S... Read Post »
Mergers & AcquisitionsBoehringer and Zai Lab Sharpen a Two-Edge Strategy to Cut Through DLL3 Tumo... Boehringer and Zai Lab Sharpen a Two-Edge Strategy to Cut Through DLL3 Tumo... Read Post »
Mergers & AcquisitionsMesoblast Expands Its Cell Therapy Territory with CAR-Powered Precision Pla... Mesoblast Expands Its Cell Therapy Territory with CAR-Powered Precision Pla... Read Post »
Mergers & AcquisitionsGSK’s Bold Lungstrike: Acquiring 35Pharma to Unleash HS235 on PH GSK’s Bold Lungstrike: Acquiring 35Pharma to Unleash HS235 on PH Read Post »
Regulatory & Health PolicyFDA Sets the Coordinates for Safe Navigation in Genome Editing FDA Sets the Coordinates for Safe Navigation in Genome Editing Read Post »
Mergers & AcquisitionsAbbVie Builds Pain Portfolio Through Broad Licensing Pact With Haisco AbbVie Builds Pain Portfolio Through Broad Licensing Pact With Haisco Read Post »
Mergers & AcquisitionsNovo Nordisk Taps OpenAI to Supercharge the Drug Discovery Engine Novo Nordisk Taps OpenAI to Supercharge the Drug Discovery Engine Read Post »
Mergers & AcquisitionsRegeneron and Telix Set 50/50 Course for Targeted Radiopharma Expansion Regeneron and Telix Set 50/50 Course for Targeted Radiopharma Expansion Read Post »
Mergers & AcquisitionsBoehringer, Click Move CT-155 to Frontline in Schizophrenia Boehringer, Click Move CT-155 to Frontline in Schizophrenia Read Post »
Mergers & AcquisitionsFrom Images to Insights: Imagene AI Partners Daiichi Sankyo From Images to Insights: Imagene AI Partners Daiichi Sankyo Read Post »
Mergers & AcquisitionsRoche, C4 Therapeutics Launch “Two-in-One” Targeted Cancer Strategy Roche, C4 Therapeutics Launch “Two-in-One” Targeted Cancer Strategy Read Post »
Mergers & AcquisitionsCosette Pharmaceuticals Acquires SYMPAZAN Portfolio from Assertio Holdings Cosette Pharmaceuticals Acquires SYMPAZAN Portfolio from Assertio Holdings Read Post »
Clinical Trials Mergers & AcquisitionsBoehringer–BioNTech Partner on ES-SCLC Immunotherapy Trial Boehringer–BioNTech Partner on ES-SCLC Immunotherapy Trial Read Post »
Mergers & AcquisitionsAstellas Taps Dyno’s AI-Designed AAV Capsid to Tackle Muscle Gene Therapy... Astellas Taps Dyno’s AI-Designed AAV Capsid to Tackle Muscle Gene Therapy... Read Post »
Mergers & AcquisitionsShionogi Secures Up to $482 Million BARDA Project BioShield Contract for Fe... Shionogi Secures Up to $482 Million BARDA Project BioShield Contract for Fe... Read Post »
Health Tidings Mergers & AcquisitionsHalozyme and Vertex Sign Global Licensing Deal for Hypercon Drug Delivery T... Halozyme and Vertex Sign Global Licensing Deal for Hypercon Drug Delivery T... Read Post »
Health Tidings Mergers & AcquisitionsBiogen Licenses Alloy AntiClastic ASO Technology Biogen Licenses Alloy AntiClastic ASO Technology Read Post »
Health Tidings Mergers & AcquisitionsAC Immune Expands Tau Program Under Lilly Agreement AC Immune Expands Tau Program Under Lilly Agreement Read Post »
Mergers & AcquisitionsGilead Bolsters ADC Strategy with Tubulis Acquisition Worth Up to $5B Gilead Bolsters ADC Strategy with Tubulis Acquisition Worth Up to $5B Read Post »
Health Tidings Mergers & AcquisitionsNeurocrine to Acquire Soleno, Strengthening Rare Disease Portfolio with VYK... Neurocrine to Acquire Soleno, Strengthening Rare Disease Portfolio with VYK... Read Post »
Mergers & AcquisitionsDenali Therapeutics Inc. Regains Full Rights to DNL593 After Takeda Pharmac... Denali Therapeutics Inc. Regains Full Rights to DNL593 After Takeda Pharmac... Read Post »
Health Tidings Mergers & AcquisitionsRegeneron Partners with TriNetX to Leverage 300 Million Patient Records for... Regeneron Partners with TriNetX to Leverage 300 Million Patient Records for... Read Post »
Mergers & AcquisitionsLupin Completes VISUfarma Acquisition, Expands European Ophthalmology Portf... Lupin Completes VISUfarma Acquisition, Expands European Ophthalmology Portf... Read Post »
Health Tidings Mergers & AcquisitionsZai Lab, Amgen Partner to Advance DLL3 Dual-Targeting Strategy in SCLC Zai Lab, Amgen Partner to Advance DLL3 Dual-Targeting Strategy in SCLC Read Post »
Mergers & AcquisitionsBioVersys Strikes Ansamycin Antibiotic Deal with Hackensack Meridian Health BioVersys Strikes Ansamycin Antibiotic Deal with Hackensack Meridian Health Read Post »
Mergers & AcquisitionsAxsome-Takeda Deal Brings Balipodect into Late-Stage CNS Development Axsome-Takeda Deal Brings Balipodect into Late-Stage CNS Development Read Post »
Health Tidings Mergers & AcquisitionsBiogen’s $5.6B Apellis Deal Boosts Immunology and Rare Disease Portfolio Biogen’s $5.6B Apellis Deal Boosts Immunology and Rare Disease Portfolio Read Post »
